This approach offers an enhanced therapeutic effect with minimal systemic toxicity, addressing one of oncology’s ...
BOAS is a platform for building multivalent viral protein immunogens without a scaffold, such as a nanoparticle, to elicit broad influenza vaccine responses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback